BNP and NT-proBNP levels in patients with sepsis

被引：18
|
作者：
Li, Nan [1 ]
Zhang, Yu [1 ]
Fan, Songtao [2 ]
Xing, Jing [1 ]
Liu, Hongyang [1 ]
机构：
[1] Dalian Med Univ, Emergency Dept, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
[2] Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2013年 / 18卷
关键词：
Systemic Inflammatory Response Syndrome; B-Type Natriuretic Peptide; Multiple Organ Dysfunction Syndrome; Atrial Natriuretic Peptide; Review; BRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; HEART-FAILURE; SEPTIC SHOCK; VENTRICULAR DYSFUNCTION; PROCALCITONIN; BIOCHEMISTRY; MARKER; EPIDEMIOLOGY; DEPRESSION;
D O I：
10.2741/4175
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent years, BNP and NT-proBNP have been the focus of studies evaluating the severity and prognosis of sepsis. In this study, we will review the role of BNP and NT-proBNP in sepsis.
引用
收藏
页码：1237 / 1243
页数：7
相关论文
共 50 条
  • [21] The integration of BNP and NT-proBNP into clinical medicine
    Mueller, Christian
    Breidthardt, Tobias
    Laule-Kilian, Kirsten
    Christ, Michael
    Perruchoud, Andre P.
    SWISS MEDICAL WEEKLY, 2007, 137 (1-2) : 4 - 12
  • [22] 正确解读BNP和NT-proBNP
    韩治伟
    刘晓飞
    王勇
    中日友好医院学报, 2013, 27 (02) : 113 - 115
  • [23] BNP和NT-proBNP的比较
    姜熙鹏
    中国药物经济学, 2012, (03) : 265 - 266
  • [24] BNP/NT-ProBNP and Cardiac Pacing: A Review
    Wang, Ru-Xing
    Guo, Tao
    Li, Xiao-Rong
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (06): : 794 - 799
  • [25] Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure
    Hogenhuis, Jochern
    Voors, Adriaan A.
    Jaarsma, Tiny
    Hoes, Arno W.
    Hillege, Hans L.
    Kragten, Johannes A.
    van Veldhuisen, Dirk J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (08) : 787 - 794
  • [26] Monitoring of BNP, NT-proBNP and xylosyltransferase I levels in patients with ventricular assist device support
    Götting, C
    Schöttler, M
    Prante, C
    Müller, S
    Schön, S
    Brinkmann, T
    Milting, H
    El Banayosy, A
    Körfer, R
    Kuhn, J
    Kleesiek, K
    CLINICAL CHEMISTRY, 2004, 50 (06) : A25 - A25
  • [27] ProBNP, BNP, and NT-proBNP circulating levels are altered by hemodiafiltration but still correlate with ventricular function in chronic hemodialysis patients
    Bargnoux, Anne-Sophie
    Klouche, Kada
    Fareh, Jeannette
    Barazer, Isabelle
    Dupuy, Anne-Marie
    Leray-Moragues, Helene
    Villard-Saussine, Sylvie
    Giuliani, Isabelle
    Cristol, Jean-Paul
    Canaud, Bernard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 315 - 315
  • [28] Genetic variation in the BNP-gene: effect on NT-proBNP levels and results of NT-proBNP-guided therapy
    Van Wijk, SSandra
    Wijnen, P.
    Bekers, O.
    Tobler, D.
    Rickli, H.
    Erne, P.
    Rickenbacher, P.
    Pfisterer, M. E.
    Volders, P.
    Brunner-La Rocca, H. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 125 - 126
  • [29] BNP and NT-PROBNP as new markers of cardiac dysfunction in shock patients
    Anglès, O
    Baixas, C
    Sanchez-Verlaan, P
    Mucke, F
    Galinier, M
    Génestal, M
    INTENSIVE CARE MEDICINE, 2003, 29 : S178 - S178
  • [30] NT-proBNP and BNP variability in obese patients without heart failure
    St Peter, JV
    Murakami, MM
    Quist, HE
    Hartley, GG
    Apple, FS
    CLINICAL CHEMISTRY, 2005, 51 : A28 - A28
12345